nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

22.05.2019 | Image of the Month

FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis

verfasst von: Frederik L. Giesel, Claus Peter Heussel, Thomas Lindner, Manuel Röhrich, Hendrik Rathke, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn, Clemens Kratochwil

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Excerpt

FDG-PET/CT is the current mainstay of lung cancer staging and presents favorable sensitivity and specificity in comparison to morphological diagnostic means especially for mediastinal lymph-node assessment. However, high physiological uptake in the brain requires additional cerebral magnetic resonance imaging to complete M-staging. Although not a major limitation, the dependency of FDG on blood sugar and the need of preparatory fasting and to recline during the 1-h uptake phase is inconvenient, hampering smooth patient workflow [1]. …

Flechsig P, Mehndiratta A, Haberkorn U, Kratochwil C, Giesel FL. PET/MRI and PET/CT in lung lesions and thoracic malignancies. Semin Nucl Med. 2015;45(4):268–81. https://doi.org/10.1053/j.semnuclmed.2015.03.004.CrossRefPubMed

Lindner T, Loktev A, Altmann A, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59(9):1415–22. https://doi.org/10.2967/jnumed.118.210443.CrossRefPubMed

Loktev A, Lindner T, Mier W, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59(9):1423–9. https://doi.org/10.2967/jnumed.118.210435.CrossRefPubMedPubMedCentral

Giesel F, Kratochwil C, Lindner T, et al. FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med. 2019;60(3):386–392. https://doi.org/10.2967/jnumed.118.215913.

Kratochwil C, Flechsig P, Lindner T, et al. FAPI-PET/CT: mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer. J Nucl Med 2019 6. doi: https://doi.org/10.2967/jnumed.119.227967.

Titel: FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis
verfasst von: Frederik L. Giesel
Claus Peter Heussel
Thomas Lindner
Manuel Röhrich
Hendrik Rathke
Hans-Ulrich Kauczor
Jürgen Debus
Uwe Haberkorn
Clemens Kratochwil
Publikationsdatum: 22.05.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04346-z

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis

Excerpt

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

A prospective observational study on the long-term results of 90Yttrium citrate radiosynoviorthesis of synovitis in osteoarthritis of the knee joint

Transfer of yttrium-90 to breast milk during radiosynoviorthesis of the knee joint

Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study

Call to arms: need for radiobiology in molecular radionuclide therapy

3′-Deoxy-3’-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies

Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617